MSLP - MusclePharm Corporation

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/201512/31/2014
Total Revenue102,155132,499166,858177,389
Cost of Revenue70,01085,741106,985121,379
Gross Profit32,14546,75859,87356,010
Operating Expenses
Research Development6421,8694,2513,997
Selling General and Administrative34,93550,36183,93471,389
Non Recurring----
Others----
Total Operating Expenses105,587137,971195,170196,765
Operating Income or Loss-3,432-5,472-28,312-19,376
Income from Continuing Operations
Total Other Income/Expenses Net-7,3992,313-23,4415,577
Earnings Before Interest and Taxes-3,432-5,472-28,312-19,376
Interest Expense-3,261-1,642-779-201
Income Before Tax-10,831-3,159-51,753-13,799
Income Tax Expense14231810533
Minority Interest----
Net Income From Continuing Ops-10,973-3,477-51,858-13,832
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-10,973-3,477-51,858-13,832
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-10,973-3,477-51,858-13,832